The structure and function of acid proteases. V. Comparative studies on the specific inhibition of acid proteases by diazoacetyl-DL-norleucine methyl ester, 1,2-epoxy-3-(p-nitrophenoxy) propane and pepstatin.
Comparative studies have been made on the effects of diazoacetyl-DL-norleucine methyl ester (DAN), 1,2-epoxy-3-(p-nitrophenoxy)propane (EPNP) and pepstatin on acid proteases, including those from Acrocylindrium sp., Aspergillus niger, Aspergillus saitoi, Mucor pusillus, Paecilomyces varioti, Rhizopus chinensis, and Trametes sanguinea, and also porcine pepsin [EC 3.4.23.1] and calf rennin [EC 3.4.23.4] for comparative purposes. These enzymes were rapidly inactivated at similar rates and in 1:1 stiochiometry by reaction with DAN in the presence of cupric ions. The pH profiles of inactivation of these enzymes were similar and had optima at pH 5.5 to 6. They were also inactivated at similar rates by reaction with EPNP, with concomitant incorporation of nearly 2 EPNP molecules per molecule of enzyme. The pH profiles of inactivation were again similar and maximal inactivation was observed at around pH 3 to 4. Some of the EPNP-inactivated enzymes were treated with DAN and shown still to retain reactivity toward DAN. All these enzymes were inhibited strongly by pepstatin, and the reactions of DAN and EPNP with them were also markedly inhibited by prior treatment with pepstatin. These results indicate that the active sites of these enzymes are quite similar and that they presumably have at least two essential carboxyl groups at the active site in common, one reactive with DAN in the presence of cupric ions and the other reactive with EPNP, as has already been demonstrated for porcine pepsin and calf rennin. Pepstatin appears to bind at least part of the active site of each enzyme in a simmilar manner.
D000614:Aminocaproates / Q000494:pharmacology*; D001391:Azo Compounds / Q000494:pharmacology; D001419:Bacteria / Q000201:enzymology; D001665:Binding Sites; D003300:Copper / Q000494:pharmacology; D004852:Epoxy Compounds / Q000494:pharmacology; D005658:Fungi / Q000201:enzymology; D006863:Hydrogen-Ion Concentration; D009596:Nitrophenols / Q000494:pharmacology; D009646:Norleucine / Q000031:analogs & derivatives / Q000494:pharmacology*; D009842:Oligopeptides / Q000494:pharmacology*; D010434:Pepsin A / Q000378:metabolism; D010436:Pepstatins / Q000494:pharmacology*; D011480:Protease Inhibitors; D012083:Renin / Q000378:metabolism
D000614:Aminocaproates; D001391:Azo Compounds; D004852:Epoxy Compounds; D009596:Nitrophenols; D009842:Oligopeptides; D010436:Pepstatins; D011480:Protease Inhibitors; D003300:Copper; D009646:Norleucine; D010434:Pepsin A; D012083:Renin